Triazole-linked reduced amide isosteres: An approach for the fragment-based drug discovery of anti-Alzheimer’s BACE1 inhibitors
Authors:
- Christopher J. MonceauxChristopher J. Monceaux
- Chiho Hirata-FukaeCHChiho Hirata-Fukae
- Polo C.-H. LamPLPolo C.-H. Lam
- Maxim M. TotrovMTMaxim M. Totrov
- Yasuji MatsuokaYMYasuji Matsuoka
- Paul R. CarlierPaul R. Carlier
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (13) , 3992-3996
Abstract
No abstract availableKeywords
Funding Information
- Virginia Alzheimer’s and Related Diseases Research Award Fund
- Virginia Tech-Georgetown Consortium for Drug Discovery
This publication has 21 references indexed in Scilit:
- 2009 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2009
- Discovery of Oxadiazoyl Tertiary Carbinamine Inhibitors of β-Secretase (BACE-1)Journal of Medicinal Chemistry, 2006
- BACE-1 inhibition by a series of ψ[CH2NH] reduced amide isosteresBioorganic & Medicinal Chemistry Letters, 2006
- Microtiter plate based chemistry and in situ screening: a useful approach for rapid inhibitor discoveryOrganic & Biomolecular Chemistry, 2006
- 1,2,3‐Triazole as a Peptide Surrogate in the Rapid Synthesis of HIV‐1 Protease InhibitorsChemBioChem, 2005
- Freeze-frame inhibitor captures acetylcholinesterase in a unique conformationProceedings of the National Academy of Sciences, 2004
- Rapid Diversity‐Oriented Synthesis in Microtiter Plates for In Situ Screening of HIV Protease InhibitorsChemBioChem, 2003
- Alzheimer Disease in the US PopulationArchives of Neurology, 2003
- β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACEScience, 1999
- Alzheimer's Disease: The Amyloid Cascade HypothesisScience, 1992